Rapid Dose Therapeutics Corp. filed its Annual on Jun 28, 2023 for the period ending Feb 28, 2023. In this report its auditor, Chartered Professional Accountants, gave an unqualified opinion expressing doubt that the company can continue as a going concern.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.27 CAD | +5.88% | +28.57% | +63.64% |
Mar. 25 | Rapid Dose Therapeutics Corp. announced that it expects to receive CAD 6 million in funding | CI |
Feb. 08 | Rapid Dose Therapeutics Corp. Appoints Angela O'Leary to the Board of Directors | CI |
1st Jan change | Capi. | |
---|---|---|
+63.64% | 22.5M | |
-8.89% | 187M |
- Stock Market
- Equities
- DOSE Stock
- News Rapid Dose Therapeutics Corp.
- Rapid Dose Therapeutics Corp. Auditor Raises 'Going Concern' Doubt